Aralez Pharma Cash Flow - Quarterly (OTCMKTS:ARLZQ)

Add to My Stocks
$0.02 $0 (0%) ARLZQ stock closing price Sep 20, 2018 (Closing)
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
-19.74M-125.2M-79.43M-54.99M-27.47M-102.97M-71.86M-51.26M-33.78M-37.78M
Depreciation Depletion Amortization Cash-Flow9.39M35.9M26.89M17.83M8.9M13.05M6.07M3.51M1.32M-
Net Increase (Decrease) in Assets Liabilities23.72M12.86M12.42M19.83M22.08M-2.19M-6.25M-10.95M-7.72M13.73M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net5.2M47.65M20.92M13.22M6.98M8.38M3.37M--1.13M7.24M
Net Cash from (used by) Operating Activities
18.57M-28.78M-19.19M-4.11M10.48M-83.73M-68.66M-57.72M-41.31M-16.78M
Increase (Decrease) in Prop Plant And Equipment-0.03M-1.29M-1.17M-1.17M-1.46M-4.16M-2.01M-0.65M-0.39M-0.24M
Acquisition Disposition of Subsidiaires------217.88M-42.88M-17.88M-17.88M-
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities--0.21M-0.21M-0.21M-0.21M-0.71M-0.8M-0.59M-2.47M
Net Cash from (used by) Investment Activities
-0.03M-1.51M-1.39M-1.39M-1.67M-222.76M-45.7M-19.13M-18.28M2.23M
Issuance (Purchase) of Equity Shares-----75M75M75M75M1.73M
Issuance (Repayment) of Debt Securities-----270.3M70.4M70.4M74.32M-
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-3.42M-6.34M-4.13M-3.97M-0.01M---0.49M-0.7M-2.95M
Net Cash from (used by) Financing Activities
-3.36M-6.23M-4.02M-3.86M-0.01M346.26M145.74M144.91M148.62M-1.21M
Effect of Exchange Rate Changes on Cash-0.18M----0.01M-----
Net Change in Cash & Cash Equivalents
14.99M-36.05M-24.21M-9.16M8.78M40.12M31.71M68.21M89.21M-15.76M
Cash & Equivalents at Beginning of Year64.94M24.81M40.58M32.82M68.41M104.99M31.23M23.27M26.11M37.66M
Cash & Equivalents at Year End43.88M28.89M40.73M55.77M73.72M64.94M56.53M93.03M114.02M24.81M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Key Financial Ratios For Aralez Pharma Cash Flow

FCF margin
0.49

Quarterly Cash Flow Statements For Aralez Pharmaceuticals Inc Peers

Anika Therapeutics cash flow, Auris Medical cash flow, Skinvisible cash flow